Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CP✓SelectedUSD · CPMRNA vs CP performance historyLatest closeAs of-3.36%09/09
Stock and ETF performance explorer

MRNA vs CP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-70.3%
CP return
+30.0%
Excess return
-100.2%
Maximum drawdown
-95.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCPExcessAlpha
1D-3.4%-1.2%-2.2%-2.7%
7D-10.1%+0.6%-10.7%-10.4%
30D+126.7%-0.5%+127.2%+127.7%
3M+184.1%+0.1%+184.0%+182.8%
6M+143.3%+7.8%+135.5%+130.8%
YTD+359.9%+22.9%+337.0%+302.7%
1Y+454.2%+21.3%+432.9%+389.4%
3Y+26.0%+20.4%+5.6%+13.1%
5Y-70.3%+34.9%-105.2%-72.9%
All-70.3%+30.0%-100.2%-72.9%

Cumulative growth

Daily Returns

Daily percentage return beside CP.

Daily Out/Under-Performance

Portfolio return minus CP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling